GSK holds block window open with $750m Aspen sale
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Equity

GSK holds block window open with $750m Aspen sale

Pharmaceutical firm GlaxoSmithKline is selling a $750m stake in South African peer Aspen Pharmacare through a block trade on Tuesday night, continuing a strong run of blocks in recent weeks.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article